Bax inhibition protects against free fatty acid-induced lysosomal permeabilization. - Wikidata - awgldk - TriplyDB

Bax inhibition protects against free fatty acid-induced lysosomal permeabilization.

Bax inhibition protects against free fatty acid-induced lysosomal permeabilization.

http://www.wikidata.org/entity/Q34665604

about

Lysosomal storage diseases and the heat shock response: convergences and therapeutic opportunities Regulated necrotic cell death: the passive aggressive side of Bax and Bak A hierarchical approach employing metabolic and gene expression profiles to identify the pathways that confer cytotoxicity in HepG2 cells.Identification of genes that regulate multiple cellular processes/responses in the context of lipotoxicity to hepatoma cells.A novel method incorporating gene ontology information for unsupervised clustering and feature selection.Emerging roles for lipids in non-apoptotic cell death Application of metabolic flux analysis to identify the mechanisms of free fatty acid toxicity to human hepatoma cell line.Heat shock protein 70 inhibits apoptosis in cancer cells through simultaneous and independent mechanisms Hepatocyte death: a clear and present danger.The vascular contribution to Alzheimer's disease.The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity Apoptotic sphingolipid ceramide in cancer therapy.Apoptosis as a mechanism for liver disease progression.Renal lipid metabolism and lipotoxicity.An apoptosis panel for nonalcoholic steatohepatitis diagnosis Glucose and palmitate uncouple AMPK from autophagy in human aortic endothelial cells Eucommia ulmoides Oliver extract, aucubin, and geniposide enhance lysosomal activity to regulate ER stress and hepatic lipid accumulation Eucommia ulmoides cortex, geniposide and aucubin regulate lipotoxicity through the inhibition of lysosomal BAX.Mechanisms of lipotoxicity in NAFLD and clinical implications Hsp72 mediates TAp73α anti-apoptotic effects in small cell lung carcinoma cells.Cryptococcus neoformans-induced macrophage lysosome damage crucially contributes to fungal virulence.Diagnosis and evaluation of nonalcoholic fatty liver disease.Glycogen Synthase Kinase-3β and Caspase-2 Mediate Ceramide- and Etoposide-Induced Apoptosis by Regulating the Lysosomal-Mitochondrial Axis.Enhancing lysosome biogenesis attenuates BNIP3-induced cardiomyocyte death Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice.Adipocyte hypertrophy is associated with lysosomal permeability both in vivo and in vitro: role in adipose tissue inflammation Myristic acid potentiates palmitic acid-induced lipotoxicity and steatohepatitis associated with lipodystrophy by sustaning de novo ceramide synthesis.Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases.Qushi Huayu Decoction Inhibits Hepatic Lipid Accumulation by Activating AMP-Activated Protein Kinase In Vivo and In Vitro.Lysosomal cysteine cathepsins: signaling pathways in apoptosis.Translocation of iron from lysosomes into mitochondria is a key event during oxidative stress-induced hepatocellular injury.Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment.Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease.Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients.Repression of PKR mediates palmitate-induced apoptosis in HepG2 cells through regulation of Bcl-2.Lysosomal serine protease CLN2 regulates tumor necrosis factor-alpha-mediated apoptosis in a Bid-dependent manner Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal Regulation of apoptosis-associated lysosomal membrane permeabilization.Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications.

P2860

Q27004531-C0E28BE0-2DA9-4F78-9100-D37E2AE2EEDC Q27021740-596BF71A-D122-45FE-902C-93FEA0AD3B34 Q33284459-383E94D8-C215-4808-BBF7-B51CF32E3541 Q33302071-0BBF418F-C0AB-4053-B050-76F62C97AA62 Q33389178-F05FAB47-35B0-4C40-9FF5-CA5A5B2CD963 Q33586741-12DAE7A4-134C-493D-BC22-D658FBA6C999 Q33762092-E5E79E3A-5315-4A4F-BC80-E2EEDEA2DB51 Q33958778-CAF7972A-E2A1-4FFD-BCD7-6C709CEE873B Q34147508-24517CC1-3DD5-457D-8903-29B61FE59F18 Q34178526-E0B29116-D885-4D8C-BC74-1572E1279857 Q34512981-30D5C878-4C49-4321-A9D9-0E407B719827 Q34736760-87F2E431-E7AF-47F0-94C4-8C617E05BCB0 Q34764471-8E273050-4141-4393-A532-FC18577CA7E5 Q34825296-54C0A7A9-674D-4980-9DC8-8BDEFB42575D Q34995562-8479D4EC-933D-4ADF-8263-B1B11BB36729 Q35034843-C7FC8EDE-E027-499B-8E5D-93C044736952 Q35069547-7C45D686-B808-4ABA-97EA-BE90283CB8E3 Q35106009-771E30AC-FAB9-4424-832F-EE0132E4913F Q35132916-A4D80F0E-D425-4D29-A1DC-33ED02895334 Q35216158-1FBC872C-9FA9-4C2E-9730-9B801649C8A0 Q35231374-BA6D059A-3595-41AF-90DD-AAE7670C5F32 Q35495753-2F6ABA07-7CC1-41B8-8376-8EEEAAE3D38F Q35884004-BA520376-B6BE-4BCE-B238-EC9159205241 Q35916125-2C7D1F6A-A162-43D3-823D-3F5E6EEA80A8 Q36302806-A96BF5D9-6686-4D49-B755-1DEE05BC24A7 Q36309443-ABB94C4B-3348-4BA0-8D70-6F77310A4A08 Q36561524-0AE84867-B9C2-4F17-A97B-FB83052B1B13 Q36572087-9498EFBF-73E4-44EE-ADE5-5C5240A17636 Q36734149-1579E2D8-9502-4F2A-A95F-D4EB4EADF33D Q36841861-A1896B2E-1B3E-40D7-BF7C-95170710B14E Q36964130-3A537228-33B3-40E4-9AB7-420C47AE6BF8 Q37051418-DC33E2A8-9874-4ED3-8C9F-F6857F8F6A80 Q37062751-09D46053-4999-49C7-B7F1-F6951B496ED0 Q37066731-B270A9B0-B627-4106-A001-A0343969132C Q37149001-D48E948F-5FE2-43A9-89AD-21BC7CE35B2D Q37160925-240CC0CF-9F33-4675-B9CE-4E10B163C8B6 Q37310283-FC8B8B3D-1151-44CC-B2A4-95616294985F Q37578517-3CFCFA04-E740-4030-9A71-322938755434 Q37676015-A35ABA5B-EB95-48F2-9D23-165A5F45D0A0 Q37863133-3B543DB4-2CF2-451F-89C1-59995425A84B

P2860

Bax inhibition protects against free fatty acid-induced lysosomal permeabilization.

http://www.wikidata.org/entity/Q34665604

description

2006 nî lūn-bûn

@nan

2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Bax inhibition protects against free fatty acid-induced lysosomal permeabilization.

@ast

Bax inhibition protects against free fatty acid-induced lysosomal permeabilization.

@en

Bax inhibition protects against free fatty acid-induced lysosomal permeabilization.

@nl

type

label

Bax inhibition protects against free fatty acid-induced lysosomal permeabilization.

@ast

Bax inhibition protects against free fatty acid-induced lysosomal permeabilization.

@en

Bax inhibition protects against free fatty acid-induced lysosomal permeabilization.

@nl

prefLabel

Bax inhibition protects against free fatty acid-induced lysosomal permeabilization.

@ast

Bax inhibition protects against free fatty acid-induced lysosomal permeabilization.

@en

Bax inhibition protects against free fatty acid-induced lysosomal permeabilization.

@nl

P1433

Q34665604-D6A0FDEF-F9CE-4CCB-903A-B319DB6751BC

P1476

Q34665604-9B680003-F61A-498C-881A-92BF770FEDDE

P2093

Q34665604-0A722A90-4133-4C2D-A60F-4EE4934FAEBF

Q34665604-78947C3D-88E4-42A4-B25A-D4F86609E475

Q34665604-7B61B81D-7D92-4114-BC87-BC5D5D66BC15

Q34665604-9A3169DE-7C58-41D4-A91B-B6DEAC6003C1

P2860

Q34665604-067C6E0A-E18F-4A26-B525-C959361E6DE0

Q34665604-08DDC272-DA5A-4A05-9A03-1EFB1AA7F857

Q34665604-0A1AA24C-3321-466A-8432-DBB843EC56D2

Q34665604-16F6A8F9-F7C4-4886-95E5-9C30D4759F45

Q34665604-1F4DABEF-B3F5-4A4A-BD29-142AF6FA63E9

Q34665604-26C8F95D-3048-43CC-B893-04846C68C1C1

Q34665604-2A6DB69E-AAC5-413F-906A-24750085F83B

Q34665604-2F0EC61A-B18F-49AE-8A78-D7DE984D5C16

Q34665604-37738AB7-EF3C-488D-AB3A-F6457AFB772C

Q34665604-397F9040-5610-4694-8442-E0356D60B065

P304

Q34665604-1C69CB29-2F59-44E1-BD4D-F41C3D73C368

P31

Q34665604-D8681E67-9350-443E-A5DE-BAE0D88CB1E4

P356

Q34665604-7E1EC03B-7EC6-4C1F-A697-D651FEF1462F

P433

Q34665604-4714EC71-FCCC-4FEE-8BA2-DD7DB945A928

P478

Q34665604-4D1A26C9-031F-4FF0-9A30-8ABFBD48F680

P50

Q34665604-362492E3-C10A-4A42-9512-E960AB2522CA

P577

Q34665604-FA361BEB-BECB-40D9-9E8B-597A5D0ED519

P5875

Q34665604-7E7D57AE-0919-43F1-9AF6-B13354526A2F

P698

Q34665604-1709FEB9-8F07-4BD4-8FE1-D86E8003FF0F

P921

Q34665604-A27AAFEF-4892-4514-9B6E-89B9530B051E

P932

Q34665604-EF54DDCB-7182-448B-AA1F-11F5BF329D1F

P356

AJPGI.00509.2005

P1433

American Journal of Physiology - Gastrointestinal and Liver Physiology

P1476

Bax inhibition protects against free fatty acid-induced lysosomal permeabilization.

@en

P2093

Ariel E Feldstein

http://www.w3.org/2001/XMLSchema#string

Nathan W Werneburg

http://www.w3.org/2001/XMLSchema#string

Steven F Bronk

http://www.w3.org/2001/XMLSchema#string

Zhengzheng Li

http://www.w3.org/2001/XMLSchema#string

P2860

Cathepsin D targeted by acid sphingomyelinase-derived ceramide

Saturated free fatty acids and apoptosis in microvascular mesangial cells: palmitate activates pro-apoptotic signaling involving caspase 9 and mitochondrial release of endonuclease G

Bax in murine thymus is a soluble monomeric protein that displays differential detergent-induced conformations

Steatohepatitis: a tale of two "hits"?

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

The Bcl2 family: regulators of the cellular life-or-death switch

Molecular mediators of hepatic steatosis and liver injury

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

Nonalcoholic fatty liver disease

Lipotoxic diseases.

P304

G1339-46

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPGI.00509.2005

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

290

http://www.w3.org/2001/XMLSchema#string

P50

Gregory J Gores

P577

2006-02-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7291833

http://www.w3.org/2001/XMLSchema#string

P698

16484678

http://www.w3.org/2001/XMLSchema#string

P921

P932

3056273

http://www.w3.org/2001/XMLSchema#string